Search research articles
Contact Us
Filters
Showing results (51-60 of 313) with videos related to
Page
of 32
Sort By:
European Journal of Haematology
|
January 31, 2024
Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications
Antonella Bruzzese, Enrica Antonia Martino, Francesco Mendicino, et al.
European Journal of Haematology
|
October 17, 2023
Teclistamab-cqyv in multiple myeloma
Enrica Antonia Martino, Antonella Bruzzese, Caterina Labanca, et al.
European Journal of Haematology
|
May 25, 2010
Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs
Fortunato Morabito, Massimo Gentile, Carla Mazzone, et al.
Hematological Oncology
|
February 25, 2022
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement
S Ferrero, Massimo Gentile, Luca Laurenti, et al.
Hematological Oncology
|
March 5, 2022
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement
Pier Luigi Zinzani, Maurizio Martelli, S Ferrero, et al.
Cancer
|
December 11, 2012
External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemia
Stefano Molica, Diana Giannarelli, Massimo Gentile, et al.
Tropical Medicine and Infectious Disease
|
July 26, 2024
An Update on the Entomology, Virology, Pathogenesis, and Epidemiology Status of West Nile and Dengue Viruses in Europe (2018-2023)
Federica Frasca, Leonardo Sorrentino, Matteo Fracella, et al.
British Journal of Haematology
|
August 16, 2005
The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience
Massimo Gentile, Francesca Romana Mauro, Elisabetta Calabrese, et al.
European Journal of Haematology
|
June 16, 2010
Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia
Stefano Molica, Giovanna Digiesi, Caterina Battaglia, et al.
Leukemia Research
|
March 19, 2013
The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: results of a comparative analysis
Stefano Molica, Diana Giannarelli, Massimo Gentile, et al.
Page
of 32
Search research articles
Search
Showing results (51-60 of 313) with videos related to
Sort By:
Page
of 32
European Journal of Haematology
|
January 31, 2024
Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications
Antonella Bruzzese, Enrica Antonia Martino, Francesco Mendicino, et al.
European Journal of Haematology
|
October 17, 2023
Teclistamab-cqyv in multiple myeloma
Enrica Antonia Martino, Antonella Bruzzese, Caterina Labanca, et al.
European Journal of Haematology
|
May 25, 2010
Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs
Fortunato Morabito, Massimo Gentile, Carla Mazzone, et al.
Hematological Oncology
|
February 25, 2022
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement
S Ferrero, Massimo Gentile, Luca Laurenti, et al.
Hematological Oncology
|
March 5, 2022
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement
Pier Luigi Zinzani, Maurizio Martelli, S Ferrero, et al.
Cancer
|
December 11, 2012
External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemia
Stefano Molica, Diana Giannarelli, Massimo Gentile, et al.
Tropical Medicine and Infectious Disease
|
July 26, 2024
An Update on the Entomology, Virology, Pathogenesis, and Epidemiology Status of West Nile and Dengue Viruses in Europe (2018-2023)
Federica Frasca, Leonardo Sorrentino, Matteo Fracella, et al.
British Journal of Haematology
|
August 16, 2005
The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience
Massimo Gentile, Francesca Romana Mauro, Elisabetta Calabrese, et al.
European Journal of Haematology
|
June 16, 2010
Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia
Stefano Molica, Giovanna Digiesi, Caterina Battaglia, et al.
Leukemia Research
|
March 19, 2013
The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: results of a comparative analysis
Stefano Molica, Diana Giannarelli, Massimo Gentile, et al.
Page
of 32